Gohealth Inc expected to post earnings of $2.73 a share - Earnings Preview

GoHealth

12/03/2024 13:14

* Gohealth Inc  GOCO.OQ   GOCO.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 14 for the
period ending December 31 2023
    * The Chicago Illinois-based  company is expected to report
a
8.4% increase in revenue to $363.883 million from $335.76
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Gohealth Inc is for
earnings
of $2.73 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gohealth
Inc is
$21.00​, above​ its last closing price of $13.25. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -2.90       -2.90      -2.61     Beat    10
 Jun. 30 2023  -2.33       -2.92      -3.27     Missed  -12.1
 Mar. 31 2023  -1.93       -1.96      -1.12     Beat    42.8​
 Dec. 31 2022  1.49        1.33       -7.00     Missed  -626.4
 ​​Sep.        -4.24       -4.30      -3.30     Beat    23.3
 30 2022                                                
 Jun. 30 2022  -3.75       -3.38      -2.25     Beat    33.4​
 Mar. 31 2022  -1.29       -1.33      -1.80     Missed  -35.3
 Dec. 31 2021  -2.09       2.22       30.15     Beat    1,255.
                                                        1
 This summary was machine generated March 12 at 13:14 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)